Standard BioTools Inc (NAS:LAB)
$ 1.82 -0.08 (-4.21%) Market Cap: 707.29 Mil Enterprise Value: 404.38 Mil PE Ratio: 0 PB Ratio: 1.45 GF Score: 51/100

Fluidigm Corp at Piper Sandler Healthcare Conference (Virtual) - Pre-recorded Fireside Chat Transcript

Nov 24, 2020 / 03:00PM GMT
Release Date Price: $5.76 (-3.19%)
Steven Mah
Piper Sandler - Analyst

Hello and welcome to the 32nd Annual Piper Sandler Healthcare Conference. I'm Steven Mah, Senior Research Analyst, covering tools and diagnostics. I'm very pleased to have with us today Chris Linthwaite, CEO of Fluidigm.

Most investors on the call know Fluidigm, but for the benefit of those who don't, Chris, could you please give a brief introduction to Fluidigm and then we'll get into the fireside chat.

Chris Linthwaite
Fluidigm Corporation - President & CEO

Sure, Steve, again, thank you to both you and to Piper Sandler for the invitation to this fireside chat. I regret we can't be in person for the 32nd Annual Conference.

So there's a lot that's been happening with Fluidigm in general over this course of the COVID year but really over the last four years. Contemporaneously, we had strong performance in Q3. Our COVID-19 business drove a significant amount of that growth, and we demonstrated good traction in the five to six weeks post the period of our authorization for our first Advanta Dx COVID

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot